{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:52Z","timestamp":1783149532519,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.radonc.2026.111603","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:42:37Z","timestamp":1779028957000},"page":"111603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intra-fraction target motion during MR-guided prostate stereotactic body radiotherapy: the importance of adaptive planning and real-time motion management"],"prefix":"10.1016","volume":"221","author":[{"given":"Michael J.","family":"Zelefsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8396-2095","authenticated-orcid":false,"given":"Ryan D.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheongeun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2313-1823","authenticated-orcid":false,"given":"Hesheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangkyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8244-8646","authenticated-orcid":false,"given":"Jeffrey D.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Galavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-9737","authenticated-orcid":false,"given":"David","family":"Barbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111603_b0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2017.10.020","article-title":"Magnetic resonance imaging-guided adaptive radiation therapy: a \u201cGame Changer\u201d for prostate treatment?","volume":"100","author":"Pathmanathan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111603_b0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac","volume":"151","author":"de Muinck Keizer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0360-3016(02)03008-0","article-title":"Measurement of intrafractional prostate motion using magnetic resonance imaging","volume":"54","author":"Mah","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111603_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1379596","article-title":"Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study","volume":"14","author":"Westley","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0025","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s11547-025-02014-x","article-title":"First clinical application of Comprehensive Motion Management with 1.5 T MR-linac on prostate cancer patients treated with radiotherapy: technical aspects and suggested workflow recommendations","volume":"130","author":"Nicosia","year":"2025","journal-title":"Radiol Med"},{"key":"10.1016\/j.radonc.2026.111603_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109932","article-title":"Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors","volume":"189","author":"Grimbergen","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0035","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1002\/mp.16342","article-title":"Real-time motion monitoring using orthogonal cine MRI during MR-guided adaptive radiation therapy for abdominal tumors on 1.5T MR-Linac","volume":"50","author":"Jassar","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111603_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.70005","article-title":"Commissioning of a motion management system for a 1.5T Elekta Unity MR-Linac: a single institution experience","volume":"26","author":"Smith","year":"2025","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2026.111603_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phro.2020.06.005","article-title":"Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system","volume":"15","author":"Kontaxis","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0050","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab5539","article-title":"Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy","volume":"64","author":"de Muinck Keizer","year":"2019","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2026.111603_b0055","article-title":"The impact of bladder and rectal dynamics on prostate and seminal vesicles intrafraction motion and deformation in radiotherapy","volume":"37","author":"Lunardo","year":"2026","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.eururo.2024.10.026","article-title":"Magnetic resonance imaging versus computed tomography guidance for stereotactic body radiotherapy in prostate cancer: 2-year outcomes from the MIRAGE randomized clinical trial","volume":"87","author":"Kishan","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2026.111603_b0070","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2023.12.035","article-title":"Quantifying intrafraction motion and the impact of gating for MRI-guided stereotactic radiotherapy for prostate cancer: analysis of the MRI arm from the MIRAGE phase III randomized trial","volume":"118","author":"Neylon","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111603_b0075","article-title":"Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity","volume":"54","author":"Gurewitz","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110043","article-title":"Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity","volume":"190","author":"Nicosia","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111603_b0085","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/cancers15041153","article-title":"Dosimetric impact of intrafraction prostate motion and interfraction anatomical changes in dose-escalated linac-based SBRT","volume":"15","author":"Faccenda","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2026.111603_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.zemedi.2023.05.001","article-title":"Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy","volume":"34","author":"Nachbar","year":"2024","journal-title":"Z Med Phys"},{"key":"10.1016\/j.radonc.2026.111603_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13014-025-02697-6","article-title":"AI-driven online adaptive radiotherapy in prostate cancer treatment: considerations on activity time and dosimetric benefits","volume":"20","author":"Preziosi","year":"2025","journal-title":"Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:49:35Z","timestamp":1783147775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026004421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S0167814026004421"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111603","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-fraction target motion during MR-guided prostate stereotactic body radiotherapy: the importance of adaptive planning and real-time motion management","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111603"}}